Continuous Monitoring of Respiratory Rate with Wearable Sensor in Patients Admitted to Hospital with Pneumonia Compared with Intermittent Nurse-Led Monitoring in the United Kingdom: A Cost-Utility Analysis.

Mehdi JavanbakhtMaziar Moradi-LakehAtefeh MashayekhiJowan Atkinson

Published in: PharmacoEconomics - open (2021)

Our results indicate that ARRM using RespiraSense, in addition to intermittent nurse-led monitoring of RR, in patients admitted to the hospital with pneumonia could be a cost-saving and cost-effective intervention if the minimum clinical thresholds are met.

Keyphrases

primary care
healthcare
randomized controlled trial
high intensity
acute care
tyrosine kinase
blood pressure
heart rate
cross sectional
drug induced
data analysis